CS Diagnostics Corp. (CSDX)
OTCMKTS · Delayed Price · Currency is USD
0.1000
-0.024536 (-19.70%)
At close: Apr 17, 2026

CS Diagnostics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2009FY 2008
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '09 Dec '08
25761510--
Market Cap Growth
3.72%-49.21%38005.96%---
Enterprise Value
25761510--
Last Close Price
0.100.311.160.50250000000.00800000000.00
PE Ratio
351.021073.77197840.52---
PS Ratio
122.55374.871357.453.14--
PB Ratio
0.050.150.300.00--
P/TBV Ratio
366.211120.23-71.31--
P/FCF Ratio
-12115.4313648.5042.54--
P/OCF Ratio
3960.5912115.4313648.5042.54--
EV/Sales Ratio
122.52374.881357.122.84--
EV/EBIT Ratio
-1073.80197791.40---
EV/FCF Ratio
-12115.7613645.1138.51--
Net Debt / Equity Ratio
00000.020.02
Net Debt / EBITDA Ratio
----0.160.11
Net Debt / FCF Ratio
-1.08-1.08-0.04-2.19359.400.05
Quick Ratio
0.450.450.351.590.020.02
Current Ratio
5.615.610.351.590.020.02
Return on Equity (ROE)
0.01%0.01%0.00%---
Return on Assets (ROA)
0.01%0.01%---243.68%-433.46%
Return on Capital Employed (ROCE)
0.00%0.00%0.00%0.00%12.70%23.00%
Earnings Yield
0.28%0.09%0.00%-5.57%--
FCF Yield
-0.01%0.01%2.35%--
Buyback Yield / Dilution
-82.09%-82.09%-23.92%-114621.71%--
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.